Table 3.
Prevalence of chronic health conditions among overall HSCT survivors, conventional therapy survivors, and noncancer controls
| Chronic health conditions (CTCAE grades ≥3) | HSCT survivors | Conventional therapy survivors | Noncancer controls | HSCT survivors vs conventional therapy survivors | HSCT survivors vs noncancer controls |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | OR (95% CI)* | OR (95% CI)* | |
| Cardiovascular | 17 (15.2) | 89 (8.1) | 12 (5.0) | 2.3 (1.3-4.1) | 7.4 (2.8-19.3) |
| Endocrine | 29 (25.9) | 422 (38.2) | 91 (37.6) | 0.6 (0.4-0.9) | 0.8 (0.5-1.3) |
| Gastrointestinal | 20 (17.9) | 117 (10.6) | 23 (9.5) | 2.1 (1.2-3.6) | 3.6 (1.7-7.7) |
| Neurology | 9 (8.1) | 83 (7.5) | 15 (6.2) | 1.1 (0.6-2.3) | 1.6 (0.6-4.1) |
| Ocular | 22 (19.6) | 12 (1.1) | 2 (0.8) | 23.2 (11.0-48.7) | 47.2 (9.6-231.7) |
| Pulmonary | 17 (15.2) | 60 (5.4) | 17 (7.0) | 3.5 (1.9-6.3) | 2.8 (1.3-6.1) |
| Reproductive | 60 (53.6) | 203 (18.4) | 18 (7.4) | 5.6 (3.7-8.4) | 37.1 (16.0-86.0) |
| Multiple (≥2) conditions | 53 (47.3) | 241 (21.8) | 38 (15.7) | 3.2 (2.2-4.8) | 4.8 (2.9-8.0) |
*
Age/sex-adjusted ORs.